Cytodyn Inc (CYDY)

[Northstar42]

Enrollment could be quite fast for this Trial, as there are more good reasons for doctors and patients to opt-in. PRO140 has a good safety history and has a chance to save many GvHD patient lives, so why would patients and doctors not choose to add a preventive measure on the front end of these risky procedures. I know, based on my DD, if I were facing a transplant, I'd want to take PRO140. Early or interim reports of positive results should support ODD and Breakthrough designation. I would think that would push the SP higher and improve the capital fundraising proposition. Further, with about 4000 procedures being done per month, the patient population pool should be sufficient for a rapid enrollment.